Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response

Laura Lavinia Travaini; Silvia Melania Baio; Marta Cremonesi; Concetta De Cicco; Mahila Ferrari; Giuseppe Trifirò; Gennaro Prisco; Giuseppe Viale; Marco Angelo Colleoni; Davide Radice; Gregory B. Sivolapenko; Giovanni Paganelli

doi:10.1016/j.breast.2006.12.009

Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response

Laura Lavinia Travaini, Silvia Melania Baio, Marta Cremonesi, Concetta De Cicco, Mahila Ferrari, Giuseppe Trifirò, Gennaro Prisco, Giuseppe Viale, Marco Angelo Colleoni, Davide Radice, Gregory B. Sivolapenko, Giovanni Paganelli

Research output: Contribution to journal › Article › peer-review

Abstract

Mammoscintigraphy (MMS) has been indicated as a useful tool in predicting response to therapy in cancer. However, contrasting results have been reported in the literature for breast cancer patients. The aim of this study was to explore the role of MMS in locally advanced breast cancer (LABC) patients. Fifty-one patients affected by LABC and scheduled for neoadjuvant therapy were enrolled. Breast tumor status was evaluated at baseline, during therapy and at the completion of therapy by radiological techniques and by MMS. Pre-therapy (MMS1) and post-therapy MIBI (2-methoxyisobutilysonitrile) images (MMS2-3) were analyzed. MMS1 was performed in all pts, 41 carried out MMS2 and 27 had MMS3. Tumor uptake and washout in MMS1 did not show any correlation with the therapy response. The absence of any association between tumor uptake and washout with respect to therapy response suggests that MMS is not a reliable technique to predict therapy response in LABC.

Original language	English
Pages (from-to)	262-270
Number of pages	9
Journal	Breast
Volume	16
Issue number	3
DOIs	https://doi.org/10.1016/j.breast.2006.12.009
Publication status	Published - Jun 2007

Keywords

Adjuvant therapy
Breast tumor
Mammoscintigraphy
Multidrug resistance
Therapy response

ASJC Scopus subject areas

Obstetrics and Gynaecology

Access to Document

10.1016/j.breast.2006.12.009

Fingerprint Dive into the research topics of 'Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response'. Together they form a unique fingerprint.

Cite this

Travaini, L. L., Baio, S. M., Cremonesi, M., Cicco, C. D., Ferrari, M., Trifirò, G., Prisco, G., Viale, G., Colleoni, M. A., Radice, D., Sivolapenko, G. B., & Paganelli, G. (2007). Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response. Breast, 16(3), 262-270. https://doi.org/10.1016/j.breast.2006.12.009

Neoadjuvant therapy in locally advanced breast cancer : 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response. / Travaini, Laura Lavinia; Baio, Silvia Melania; Cremonesi, Marta; Cicco, Concetta De; Ferrari, Mahila ; Trifirò, Giuseppe; Prisco, Gennaro; Viale, Giuseppe ; Colleoni, Marco Angelo ; Radice, Davide; Sivolapenko, Gregory B.; Paganelli, Giovanni.

In: Breast, Vol. 16, No. 3, 06.2007, p. 262-270.

Research output: Contribution to journal › Article › peer-review

Travaini, LL, Baio, SM, Cremonesi, M, Cicco, CD, Ferrari, M , Trifirò, G, Prisco, G, Viale, G , Colleoni, MA , Radice, D, Sivolapenko, GB & Paganelli, G 2007, 'Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response', Breast, vol. 16, no. 3, pp. 262-270. https://doi.org/10.1016/j.breast.2006.12.009

Travaini, Laura Lavinia ; Baio, Silvia Melania ; Cremonesi, Marta ; Cicco, Concetta De ; Ferrari, Mahila ; Trifirò, Giuseppe ; Prisco, Gennaro ; Viale, Giuseppe ; Colleoni, Marco Angelo ; Radice, Davide ; Sivolapenko, Gregory B. ; Paganelli, Giovanni. / Neoadjuvant therapy in locally advanced breast cancer : 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response. In: Breast. 2007 ; Vol. 16, No. 3. pp. 262-270.

@article{9577852b9784447a846ef20448edce7f,

title = "Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response",

abstract = "Mammoscintigraphy (MMS) has been indicated as a useful tool in predicting response to therapy in cancer. However, contrasting results have been reported in the literature for breast cancer patients. The aim of this study was to explore the role of MMS in locally advanced breast cancer (LABC) patients. Fifty-one patients affected by LABC and scheduled for neoadjuvant therapy were enrolled. Breast tumor status was evaluated at baseline, during therapy and at the completion of therapy by radiological techniques and by MMS. Pre-therapy (MMS1) and post-therapy MIBI (2-methoxyisobutilysonitrile) images (MMS2-3) were analyzed. MMS1 was performed in all pts, 41 carried out MMS2 and 27 had MMS3. Tumor uptake and washout in MMS1 did not show any correlation with the therapy response. The absence of any association between tumor uptake and washout with respect to therapy response suggests that MMS is not a reliable technique to predict therapy response in LABC.",

keywords = "Adjuvant therapy, Breast tumor, Mammoscintigraphy, Multidrug resistance, Therapy response",

author = "Travaini, {Laura Lavinia} and Baio, {Silvia Melania} and Marta Cremonesi and Cicco, {Concetta De} and Mahila Ferrari and Giuseppe Trifir{\`o} and Gennaro Prisco and Giuseppe Viale and Colleoni, {Marco Angelo} and Davide Radice and Sivolapenko, {Gregory B.} and Giovanni Paganelli",

year = "2007",

month = jun,

doi = "10.1016/j.breast.2006.12.009",

language = "English",

volume = "16",

pages = "262--270",

journal = "Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

number = "3",

}

TY - JOUR

T1 - Neoadjuvant therapy in locally advanced breast cancer

T2 - 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response

AU - Travaini, Laura Lavinia

AU - Baio, Silvia Melania

AU - Cremonesi, Marta

AU - Cicco, Concetta De

AU - Ferrari, Mahila

AU - Trifirò, Giuseppe

AU - Prisco, Gennaro

AU - Viale, Giuseppe

AU - Colleoni, Marco Angelo

AU - Radice, Davide

AU - Sivolapenko, Gregory B.

AU - Paganelli, Giovanni

PY - 2007/6

Y1 - 2007/6

N2 - Mammoscintigraphy (MMS) has been indicated as a useful tool in predicting response to therapy in cancer. However, contrasting results have been reported in the literature for breast cancer patients. The aim of this study was to explore the role of MMS in locally advanced breast cancer (LABC) patients. Fifty-one patients affected by LABC and scheduled for neoadjuvant therapy were enrolled. Breast tumor status was evaluated at baseline, during therapy and at the completion of therapy by radiological techniques and by MMS. Pre-therapy (MMS1) and post-therapy MIBI (2-methoxyisobutilysonitrile) images (MMS2-3) were analyzed. MMS1 was performed in all pts, 41 carried out MMS2 and 27 had MMS3. Tumor uptake and washout in MMS1 did not show any correlation with the therapy response. The absence of any association between tumor uptake and washout with respect to therapy response suggests that MMS is not a reliable technique to predict therapy response in LABC.

AB - Mammoscintigraphy (MMS) has been indicated as a useful tool in predicting response to therapy in cancer. However, contrasting results have been reported in the literature for breast cancer patients. The aim of this study was to explore the role of MMS in locally advanced breast cancer (LABC) patients. Fifty-one patients affected by LABC and scheduled for neoadjuvant therapy were enrolled. Breast tumor status was evaluated at baseline, during therapy and at the completion of therapy by radiological techniques and by MMS. Pre-therapy (MMS1) and post-therapy MIBI (2-methoxyisobutilysonitrile) images (MMS2-3) were analyzed. MMS1 was performed in all pts, 41 carried out MMS2 and 27 had MMS3. Tumor uptake and washout in MMS1 did not show any correlation with the therapy response. The absence of any association between tumor uptake and washout with respect to therapy response suggests that MMS is not a reliable technique to predict therapy response in LABC.

KW - Adjuvant therapy

KW - Breast tumor

KW - Mammoscintigraphy

KW - Multidrug resistance

KW - Therapy response

UR - http://www.scopus.com/inward/record.url?scp=34249099083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249099083&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2006.12.009

DO - 10.1016/j.breast.2006.12.009

M3 - Article

C2 - 17291755

AN - SCOPUS:34249099083

VL - 16

SP - 262

EP - 270

JO - Breast

JF - Breast

SN - 0960-9776

IS - 3

ER -